Zoetis Inc.
Zoetis Inc. (ZTS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ZTS · as of Mar 31, 2025
Ownership Breakdown
1,940
Institutional Holders
▲ 15 vs Q4
$69.25B
Total Inst. Value
▲ $965.45M vs Q4
419.23M
Shares Outstanding
freeFloat 99.80%
421.01M
13F Shares Held
▲ 1.72M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ZTS largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 41.56M | 9.28% | 9.28% | $6.84T | May 9, 2025 | ▲ 189.3K |
BLACKROCK, INC. pharmaceutical preparations | 38.48M | 8.60% | 8.60% | $6.34T | May 2, 2025 | ▼ 225.6K |
STATE STREET CORP pharmaceutical preparations | 19.80M | 4.42% | 4.42% | $3.26T | May 15, 2025 | ▼ 46.1K |
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO pharmaceutical preparations | 15.89M | 3.55% | 3.55% | $2.62T | May 13, 2025 | ▼ 118.6K |
MORGAN STANLEY pharmaceutical preparations | 12.75M | 2.85% | 2.85% | $2.10T | May 15, 2025 | ▲ 901.4K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 10.99M | 2.45% | 2.45% | $1.80T | May 13, 2025 | ▲ 368.1K |
ALLIANCEBERNSTEIN L.P. pharmaceutical preparations | 10.86M | 2.43% | 2.43% | $1.79T | May 15, 2025 | ▼ 953.0K |
POLEN CAPITAL MANAGEMENT LLC pharmaceutical preparations | 8.80M | 1.97% | 1.97% | $1.45T | May 12, 2025 | ▲ 1.31M |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 7.33M | 1.64% | 1.64% | $1.21T | May 15, 2025 | ▼ 4.17M |
NORTHERN TRUST CORP pharmaceutical preparations | 6.50M | 1.45% | 1.45% | $1.07T | May 13, 2025 | ▲ 78.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
31
Increased
+13.50M shares1
New Positions
first time holders17
Decreased
−10.46M shares0
Sold Out
fully exitedNet shares change (top 50)
+3.04M
+13.50M / −10.46M
Net new holders
+15
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ZTS insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
14
Buy transactions
4
Sell transactions
3.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
DAMELIO FRANK A director | May 13, 2026 | Purchase | 6,650 | $75.39 | $501.3K | 21.5K | Form 4 ↗ |
Bisaro Paul director | May 13, 2026 | Purchase | 2,000 | $75.88 | $151.8K | 27.9K | Form 4 ↗ |
MCCALLISTER MICHAEL B director | May 11, 2026 | Purchase | 3,000 | $77.76 | $233.3K | 24.5K | Form 4 ↗ |
Esch Kevin Executive Vice President | Apr 30, 2026 | Tax Withhold | 75 | $114.97 | $8.6K | 578 | Form 4 ↗ |
FULLER JULIE Executive Vice President | Apr 10, 2026 | Award | 550.644 | — | — | 1.8K | Form 4 ↗ |
Lagano Roxanne Executive Vice President | Apr 10, 2026 | Award | 550.644 | — | — | 30.6K | Form 4 ↗ |
Ferran Astorga Jeannette Executive Vice President | Apr 10, 2026 | Award | 4.997 | — | — | 2.3K | Form 4 ↗ |
Esch Kevin Executive Vice President | Apr 10, 2026 | Award | 1.395 | — | — | 498.386 | Form 4 ↗ |
PECK KRISTIN C Chief Executive Officer | Apr 10, 2026 | Award | 2,776.77 | — | — | 65.6K | Form 4 ↗ |
Driscoll Rimma Executive Vice President | Apr 10, 2026 | Award | 26.198 | — | — | 6.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Zoetis Inc. (ZTS) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.20%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Zoetis Inc. is VANGUARD GROUP INC, holding approximately 41.56 million shares — equal to 9.28% of outstanding shares — as of March 31, 2025.
A total of 1,940 institutional investors currently hold ZTS stock, with a combined institutional value of approximately $69.25 billion as of the most recent 13F filing period.
Frequently asked questions
ZTS ownershipZoetis Inc. (ZTS) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.28% stake. Company insiders hold 0.20%. Data sourced from SEC Form 13F as of March 31, 2025.